Anti-NMDA-receptor antibody encephalitis: Performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay

Clinica Chimica Acta

Volumn 421, Issue , 2013, Pages 1-6

  Suh Lailam, Brenda B ^a   Haven, Thomas R ^a   Copple, Susan S ^b   Knapp, Diana ^b   Jaskowski, Troy D ^a   Tebo, Anne E ^a,c  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b ARUP LABORATORIES   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; Autoimmune disease; Diagnosis; Encephalitis; NMDAR

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENCEPHALITIS; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INDIRECT IMMUNOFLUORESCENCE ANTIBODY ASSAY; MALE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY ENCEPHALITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, N-METHYL-D-ASPARTATE; SEVERITY OF ILLNESS INDEX;

EID: 84875590414     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.02.010     Document Type: Article

References (22)

1. Vitaliani R., Mason W., Ances B., Zwerdling T., Jiang Z., Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005, 58(4):594-604.
2. Dalmau J., Tuzun E., Wu H.Y., et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007, 61:25-36.
3. Dalmau J., Gleichman A.J., Hughes E.G., et al. Anti-nmda-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091-1098.
4. Vincent A., Bien C.G. Anti-nmda-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults. Lancet Neurol 2008, 7:1074-1075.
5. Florance N.R., Davis R.L., Lam C., et al. Anti-N-methyl-d-aspartate receptor (nmdar) encephalitis in children and adolescents. Ann Neurol 2009, 66:11-18.
6. Dale R.C., Irani S.R., Brilot F., et al. N-methyl-d-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009, 66:704-709.
7. Luca N., Daengsuwan T., Dalmau J., et al. Anti-N-methyl-d-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum 2011, 63(8):2516-2522.
8. Irani S.R., Bera K., Waters P., et al. N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010, 133:1655-1667.
9. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011, 10(1):63-74.
10. Gable M.S., Sheriff H., Dalmau J., Tilley D.H., Glaser C.A. The frequency of autoimmune N-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis 2012, 54(7):899-904.
11. Granerod J., Ambrose H.E., Davies N.W., et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010, 10(12):835-844.
12. Dalmau J., Bataller L. Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin North Am 2006, 20(6):1319-1335.
13. Dambinova S.A., Khounteev G.A., Izykenova G.A., Zavolokov I.G., Ilyukhina A.Y., Skoromets A.A. Blood test detecting autoantibodies to N-methyl-d-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem 2003, 49(10):1752-1762.
14. Husebye E.S., Sthoeger Z.M., Dayan M., et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis 2005, 64(8):1210-1213.
15. Tziperman B., Garty B.Z., Schoenfeld N., et al. Acute intermittent porphyria, Rasmussen encephalitis, or both?. J Child Neurol 2007, 22(1):99-105.
16. Aranow C., Diamond B., Mackay M. Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 2010, 36(1):187-201. [x-xi].
17. Prüss H., Dalmau J., Harms L., et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010, 75(19):1735-1739.
18. Irani S.R., Vincent A. Autoimmune encephalitis - new awareness, challenging questions. Discov Med 2011, 11(60):449-458.
19. Peery H.E., Day G.S., Dunn S., et al. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun Rev 2012, 11(12):863-872.
20. Tuzun E., Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 2007, 13:261-271.
21. Vincent A., Buckley C., Schott J.M., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004, 127:701-712.
22. Lai M., Hughes E.G., Peng X., et al. Ampa receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009, 65:424-434.